Sheffield risk and treatment table for cholesterol lowering for primary prevention of coronary heart disease-Reference-Cited by-同舟云学术

Sheffield risk and treatment table for cholesterol lowering for primary prevention of coronary heart disease

Published:1995-12 Issue:8988 Volume:346 Page:1467-1471
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Haq I.U,Jackson P.R,Yeo W.W,Ramsay L.E

Publisher

Elsevier BV

Subject

General Medicine

Reference30 articles.

1. Serum cholesterol, lipoproteins, and the risk of coronary heart disease;Kannel;Ann Intern Med,1971

2. The lipid research clinics coronary primary prevention trial results 1: reduction in incidence of coronary heart disease;Lipid Research Clinics Programme;JAMA,1984

3. Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart Study;Manninen;JAMA,1988

4. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S);Scandinavian Simvastatin Survival Study Group;Lancet,1994

5. By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease?;Law;BMJ,1994

Cited by 111 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Frecuencia del síndrome metabólico y estratificación del riesgo cardiovascular en pacientes con VIH mediante tres sistemas de puntuación;Revista Investigación en Salud Universidad de Boyacá;2022-06-24

2. Accelerated atherosclerosis and cardiovascular disease in systemic lupus erythematosus;Revista Colombiana de Reumatología;2021-06

3. Familial hypercholesterolaemia and its management in South Africa;CARDIOVASC J AFR;2019

4. Managing Clinical Heterogeneity: An Argument for Benefit-Based Action Limits;Journal of Engineering and Science in Medical Diagnostics and Therapy;2018-04-12

5. Atherosclerosis in systemic lupus erythematosus;Best Practice & Research Clinical Rheumatology;2017-06